FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091082 [Registered on: 17/07/2025] Trial Registered Prospectively
Last Modified On: 06/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect Of A Holistic Intervention And Caregiver Support On Adolescent Girls With Primary Dysmenorrhea 
Scientific Title of Study   Impact Of Multimodal Intervention On Adolescent Girls With Primary Dysmenorrhea Along With Caregiver Support: A Randomized Controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Harshitha V K 
Designation  Post Graduate Student 
Affiliation  Nitte Institute Of Physiotherapy  
Address  Medical Science Complex, Post Nithyananda Nagar, Deralakatte, Mangaluru

Dakshina Kannada
KARNATAKA
575018
India 
Phone  9964412923  
Fax    
Email  harshitha.24ptms11@student.nitte.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Ms Ruchita Narsia 
Designation  Assistant Professor Grade II 
Affiliation  Nitte Institute Of Physiotherapy 
Address  Medical Science Complex, Post Nithyananda Nagar, Deralakatte, Mangaluru

Dakshina Kannada
KARNATAKA
575018
India 
Phone  9408956388  
Fax    
Email  ruchita.narsia@nitte.edu.in  
 
Details of Contact Person
Public Query
 
Name  Ms Ruchita Narsia 
Designation  Assistant Professor Grade II 
Affiliation  Nitte Institute Of Physiotherapy 
Address  Medical Science Complex, Post Nithyananda Nagar, Deralakatte, Mangaluru

Dakshina Kannada
KARNATAKA
575018
India 
Phone  9408956388  
Fax    
Email  ruchita.narsia@nitte.edu.in  
 
Source of Monetary or Material Support  
Nitte Institute of Physiotherapy 
 
Primary Sponsor  
Name  Nitte Institute of Physiotherapy 
Address  Nitte Institute of Physiotherapy, Nitte Deemed to be University, Nithyananda Nagar, Deralakatte, Mangaluru, Dakshina Kannada, Karnataka 575018, India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Harshitha V K  Nitte Institute of Physiotherapy  Nitte Institute of Physiotherapy, Nitte Deemed to be University, Nithyananda Nagar, Deralakatte, Mangaluru, Dakshina Kannada, Karnataka 575018, India
Dakshina Kannada
KARNATAKA 
9964412923

harshitha.24ptms11@student.nitte.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee of Nitte Institute of Physiotherapy  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Primary Dysmenorrhea  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Control Group—Education and Management on Primary Dysmenorrhea through Pamphlet   The participants will receive an educational pamphlet regarding dysmenorrhea education and management in the beginning of the study and advised to follow the intervention for dysmenorrhea for up to 3 menstrual cycles. Baseline data will be collected using the WaLIDD score and EQ-5D. Participants will then be asked to complete the post-intervention WaLIDD score after each menstrual cycle. Participants will complete a final post-intervention WaLIDD score and EQ-5D after three menstrual cycles.  
Intervention  Multimodal Intervention Program for the Management of Primary Dysmenorrhea with Caregiver Support  Group sessions will be provided by the investigator for thirty to fifty minutes. The program begins with an education session, followed by weekly group sessions held three times a week on alternate days for three months. A new intervention will be introduced every two weeks. The intervention consists of three stages (including education) and a five-phase management plan. It is implemented before and during menstruation. Dysmenorrhea education and its management sessions are tailored to the convenience of both the participants and the school and will be conducted at their respective schools, including both the child and the caregiver for the first and last sessions. Overall, for the intervention, three sessions of thirty to fifty minutes each will be conducted every week for 12 weeks on alternate days. In the first session of Week 1 and the first session of Week 11, both the caregiver and the child will be included in the education on dysmenorrhea and its multimodal intervention. In the other sessions, only the child will undergo the interventions. The caregiver will be present during these key sessions to gain a better understanding of the process, enabling her to support her child effectively and assist in implementing the intervention at home. The intervention sessions include: Stage 1: Building the Foundation (Weeks 1–4) Weeks 1–2 (30 minutes): Education sessions on dysmenorrhea, symptoms, and self-management strategies (20 minutes in Week 1, reduced to 10 minutes in Week 2). General stretching exercises (neck, shoulders, arms, wrists, hips, thighs) for flexibility and pain relief. Weeks 3–4 (30–40 minutes): Reinforcement of dysmenorrhea education. Continued general stretching, with the addition of specific muscle stretches (iliopsoas, adductors, hamstrings). Stage 2: Expanding the Program (Weeks 5–8) Weeks 5–6 (30–40 minutes): Introduction of yoga-based postures (Baddha Konasana, Balasana, Surya Namaskara) alongside stretching routines. Weeks 7–8 (40–45 minutes): Pelvic floor muscle contractions (slow, rapid, and ascending contractions) introduced for core strengthening. Stage 3: Integration and Reinforcement (Weeks 9–12) Weeks 9–10 (45–50 minutes): Relaxation techniques (diaphragmatic breathing) incorporated to manage stress-related symptoms. Weeks 11–12 (50–55 minutes): Full implementation of the five-phase intervention on alternate days, ensuring adherence and caregiver involvement for continued support. Baseline data will be collected using the WaLIDD score and EQ-5D. Participants will then be asked to complete the post-intervention WaLIDD score after each menstrual cycle. After completing all dysmenorrhea education and management sessions (i.e., after 12 weeks), participants will complete a final post-intervention WaLIDD score and EQ-5D after three menstrual cycles. 
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  16.00 Year(s)
Gender  Female 
Details  1)Adolescent girls aged 12 to 16 years.
2)Adolescent girls with Moderate – Severe menstrual pain on WaLIDD score.
3)Participants should have a history of regular menstrual cycles (every 21 to 35
days) for at least three months prior to the study.
4)Education level of the caregiver.
5)A willingness of the adolescent girl to take part in the research.
6)Willingness of mothers or primary female caregivers to participate in the
educational and exercise component of the intervention.
 
 
ExclusionCriteria 
Details  1)Adolescent girls who are not willing to participate in the study.
2)Girls with dysmenorrhea resulting from identifiable medical conditions (e.g.,
endometriosis, pelvic inflammatory disease, uterine fibroids) will be excluded.
3)Participants who have engaged in other treatments for dysmenorrhea (such
as alternative therapies) within the last three months prior to the study.
4)Girls currently using hormonal contraceptives or other medications that affect
menstrual symptoms.
5)Physical limitations that would prevent participation in stretching, exercise, or
yoga components of the intervention. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
WaLIDD Score  The WaLIDD score will be recorded at baseline and then after each menstrual cycle following each monthly intervention session, for a total of three cycles 
 
Secondary Outcome  
Outcome  TimePoints 
EQ-5D  The EQ-5D will be assessed at baseline and at 12 weeks, that is, upon completion of the intervention following the final menstrual cycle. The pre and post scores will be then evaluated. 
 
Target Sample Size   Total Sample Size="52"
Sample Size from India="52" 
Final Enrollment numbers achieved (Total)= "52"
Final Enrollment numbers achieved (India)="52" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/08/2025 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 27/12/2025 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Primary dysmenorrhea, affecting 50%–87.8% of adolescent girls in India, causes significant pain and disrupts daily activities and quality of life. Despite its high prevalence, it is often poorly managed due to a lack of awareness, stigma, and misconceptions, with many girls enduring symptoms silently. Caregivers, especially mothers, greatly influence how girls perceive and manage menstrual pain, yet they often have limited or incorrect knowledge.

This study aims to evaluate the effectiveness of a multimodal intervention combining education, lifestyle modifications, and non-pharmacological strategies to reduce dysmenorrhea symptoms, while also assessing the impact of caregiver support. Participants will be divided into an experimental group (receiving structured sessions with caregiver involvement) and a control group (receiving pamphlet-based education only). By actively involving caregivers and educating both groups, the study seeks to improve symptom management and enhance the overall quality of life of adolescent girls.
 
Close